Newsroom
Latest News
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Tom Reed (R-NY), co-chairs of the Congressional Diabetes Caucus, today introduced new bipartisan legislation to cut the price of most insulin products by more than 75%.
The legislation – known as the Insulin Price Reduction Act – would give the nation's three makers of insulin an incentive to lower the current list price of their insulin products, which is approximately $300 a vial, to the price it was listed at in 2006, which was, on average, approximately $68 a vial.
WASHINGTON, D.C. – The Trump administration's top health official in charge of overseeing the Affordable Care Act, CMS Administrator Seema Verma, refused today to tell a key House oversight panel exactly how many Americans will likely lose their health insurance if Republicans are successful in their attempt to repeal the nation's health care law.
WASHINGTON, D.C. – Seema Verma, the Trump administration's top official charged with overseeing the Affordable Care Act, is expected to face a grilling from lawmakers on Capitol Hill Wednesday when she appears to testify before a key House oversight panel that's investigating the administration's ongoing efforts to sabotage the 2010 health care law.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), co-chair of the Congressional Diabetes Caucus, today unveiled new bipartisan legislation to reduce the skyrocketing price of insulin for millions of Americans.
WASHINGTON, D.C. – Following is a statement from U.S. Rep. Diana DeGette (D-CO) on the whistleblower complaint released today:
WASHINGTON, D.C. – Following is a statement from U.S. Rep. Diana DeGette (D-CO) on the House moving forward with a formal impeachment inquiry into the president of the United States:
"The president's own admission that he urged a foreign power to intervene in our election process constitutes an impeachable offense. We need to gather the evidence and complete this impeachment inquiry immediately given the threat this poses to our national security."
WASHINGTON, D.C. – The chair of the House Energy and Commerce Committee's Oversight and Investigations panel, U.S. Rep. Diana DeGette (D-CO), announced today that Food and Drug Administration Commissioner Ned Sharpless and principal deputy director for the Centers for Disease Control and Prevention, Dr. Anne Schuchat, will be among those testifying when the subcommittee holds its hearing Wednesday, Sept. 25, on the recent surge of vaping-related illnesses across the country.
WASHINGTON, D.C. – As young people around the country take to the streets to demand that Congress act now to solve the climate crisis, the U.S. House Natural Resources Committee will meet Tuesday to consider legislation introduced by U.S. Rep. Diana DeGette (D-CO) that would help keep one the most powerful greenhouse gases – and a leading contributor to global warming – out of our atmosphere.
WASHINGTON, D.C. – A senior Department of Health and Human Services official testified before Congress Thursday that he started sounding alarms that the Trump administration's family-separation policy would "pose an unacceptable danger to the child" 14 months before it was put in place.
WASHINGTON, D.C. – A bipartisan group of federal lawmakers – led by U.S. Reps. Diana DeGette (D-CO) and Frank Pallone (D-NJ) – is calling on the governors of 16 states to explain how their state has used billions of dollars in federal funding to combat the nation's opioid epidemic – and whether that funding is making a difference in some of the hardest-hit areas.